biotin has been researched along with Thrombosis in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (28.57) | 18.2507 |
| 2000's | 3 (21.43) | 29.6817 |
| 2010's | 7 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chaikof, EL; Dorr, BM; Haller, CA; Hanson, SR; Hinds, MT; Hurst, S; Krishnamurthy, V; Liu, DR; Marzec, UM; Qu, Z | 1 |
| Buerke, M; Drouget, L; Hauroeder, B; Kaeberich, A; Krezel, C; Maedgefessel, L; Neuhart, E; Raaz, U; Schlitt, A; Vogt, A; Werdan, K | 1 |
| Blanchemain, N; Chai, F; Haulon, S; Maton, M; Maurel, B | 1 |
| Chopp, M; Cui, Y; Li, Y; Liu, Z; Lu, M; Pekny, M; Roberts, C; Wilhelmsson, U | 1 |
| Alame, G; Freund, M; Gachet, C; Hechler, B; Magnenat, S; Mangin, PH; Petitou, M; Riehl, N | 1 |
| de Kort, M; Dubreucq, G; Meuleman, D; Motte, V; Nancy-Portebois, V; Petitou, M; van Boeckel, CA; Vogel, GM; Wisse, JA | 1 |
| Harenberg, J | 1 |
| Weitz, JI | 1 |
| Angelillo-Scherrer, A; Borgel, D; Brisset, A; Burnier, L; Capron, C; Chanson, M; Chassot, A; Fontana, P; Kwak, BR; Morel, S; Nolli, S; Roth, I; Saller, F; Sugamele, R; Sutter, E | 1 |
| Abendschein, DR; Cacheris, WP; Christy, DH; Gaffney, PJ; Lanza, GM; Miller, JG; Scott, MJ; Sharkey, AM; Wallace, KD; Wickline, SA | 1 |
| Alpert, C; Barnard, MR; Freedman, JE; Keaney, JF; Loscalzo, J; Michelson, AD | 1 |
| Cacheris, WP; Christy, DH; Fischer, SE; Gaffney, PJ; Lanza, GM; Miller, JG; Scott, MJ; Trousil, RL; Wallace, KD; Wickline, SA | 1 |
| Bosch, T; Duhr, C; Fink, E; Lennertz, A; Samtleben, W | 1 |
| Chekneva, EE; Domogatskiĭ, SP; Mamontova, AG; Shnyra, AA; Sinitsyn, VV | 1 |
3 review(s) available for biotin and Thrombosis
| Article | Year |
|---|---|
From heparin to EP217609: the long way to a new pentasaccharide-based neutralisable anticoagulant with an unprecedented pharmacological profile.
Topics: Animals; Anticoagulants; Antithrombin III; Avidin; Binding Sites; Biotin; Drug Design; Factor Xa Inhibitors; Fondaparinux; Heparin; Heparin Antagonists; Humans; Molecular Structure; Oligosaccharides; Polysaccharides; Rabbits; Structure-Activity Relationship; Thrombosis | 2009 |
Development of idraparinux and idrabiotaparinux for anticoagulant therapy.
Topics: Animals; Anticoagulants; Antithrombin III; Atrial Fibrillation; Avidin; Biotin; Carbohydrate Conformation; Carbohydrate Sequence; Drug Design; Drug Evaluation, Preclinical; Fondaparinux; Hemorrhage; Heparin Antagonists; Humans; Molecular Sequence Data; Molecular Structure; Oligosaccharides; Polysaccharides; Randomized Controlled Trials as Topic; Structure-Activity Relationship; Thrombosis; Treatment Outcome | 2009 |
Potential of new anticoagulants in patients with cancer.
Topics: Anticoagulants; Benzimidazoles; Biotin; Clinical Trials as Topic; Dabigatran; Humans; Morpholines; Neoplasms; Oligosaccharides; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Thiophenes; Thrombosis | 2010 |
1 trial(s) available for biotin and Thrombosis
| Article | Year |
|---|---|
In vitro comparison of the novel, dual-acting FIIa/FXa-inhibitor EP217609C101, unfractionated heparin, enoxaparin, and fondaparinux in preventing cardiac catheter thrombosis.
Topics: Adolescent; Adult; Anticoagulants; Biotin; Cardiac Catheters; Enoxaparin; Factor Xa Inhibitors; Female; Fondaparinux; Heparin; Humans; Male; Middle Aged; Oligosaccharides; Polysaccharides; Prothrombin; Thrombosis | 2014 |
10 other study(ies) available for biotin and Thrombosis
| Article | Year |
|---|---|
Immobilization of actively thromboresistant assemblies on sterile blood-contacting surfaces.
Topics: Amines; Aminoacyltransferases; Animals; Azides; Bacterial Proteins; Biotin; Blood Platelets; Coated Materials, Biocompatible; Cysteine Endopeptidases; Disease Models, Animal; Heparin; Immobilized Proteins; Papio; Polyethylene Glycols; Polytetrafluoroethylene; Staphylococcus aureus; Thrombomodulin; Thrombosis | 2014 |
In stent restenosis and thrombosis assessment after EP224283 injection in a rat model.
Topics: Angioplasty, Balloon; Animals; Aorta; Biotin; Cell Proliferation; Disease Models, Animal; Factor XI; Graft Occlusion, Vascular; Male; Muscle, Smooth, Vascular; Neointima; Oligosaccharides; Platelet Adhesiveness; Platelet Glycoprotein GPIIb-IIIa Complex; Rats; Rats, Wistar; Recurrence; Stents; Thrombosis | 2013 |
Beneficial effects of gfap/vimentin reactive astrocytes for axonal remodeling and motor behavioral recovery in mice after stroke.
Topics: Animals; Axons; Biotin; Brain Infarction; Calcium-Binding Proteins; Dextrans; Disease Models, Animal; Gene Expression Regulation; Glial Fibrillary Acidic Protein; Mice; Mice, Inbred C57BL; Mice, Transgenic; Microfilament Proteins; Movement Disorders; Nerve Regeneration; Nerve Tissue Proteins; Pyramidal Tracts; Recovery of Function; Stroke; Thrombosis; Versicans; Vimentin | 2014 |
EP217609, a neutralisable dual-action FIIa/FXa anticoagulant, with antithrombotic effects in arterial thrombosis.
Topics: Animals; Anticoagulants; Arteries; Avidin; Biotin; Bleeding Time; Blood Coagulation; Dose-Response Relationship, Drug; Factor Xa; Fibrinolytic Agents; Fondaparinux; Hemorrhage; Humans; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Oligosaccharides; Polysaccharides; Prothrombin; Thrombosis | 2015 |
Connexin 37 limits thrombus propensity by downregulating platelet reactivity.
Topics: Adolescent; Adult; Animals; Biotin; Bleeding Time; Blood Platelets; Connexins; Down-Regulation; Gap Junction alpha-4 Protein; Gap Junctions; Genetic Predisposition to Disease; Humans; Male; Megakaryocytes; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; Platelet Aggregation; Polymorphism, Genetic; Thrombosis; Young Adult | 2011 |
A novel site-targeted ultrasonic contrast agent with broad biomedical application.
Topics: Animals; Antibodies, Monoclonal; Avidin; Biotin; Contrast Media; Dogs; Emulsions; Femoral Artery; Fibrin; Fluorocarbons; Phosphatidylethanolamines; Scattering, Radiation; Swine; Thrombosis; Ultrasonic Therapy; Ultrasonography | 1996 |
Nitric oxide released from activated platelets inhibits platelet recruitment.
Topics: Adenosine Diphosphate; Adult; Biotin; Blood Platelets; Cyclic GMP; Cytoplasmic Granules; Flow Cytometry; Humans; Microelectrodes; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; P-Selectin; Platelet Activation; Platelet Aggregation; Serotonin; Thrombosis | 1997 |
High-frequency ultrasonic detection of thrombi with a targeted contrast system.
Topics: Avidin; Biotin; Contrast Media; Emulsions; Fluorocarbons; Humans; Image Processing, Computer-Assisted; Models, Biological; Sensitivity and Specificity; Thrombosis; Ultrasonography, Interventional | 1997 |
Ex vivo biocompatibility of avidin-agarose: a new device for direct adsorption of biotinylated antibodies from human whole blood.
Topics: Adsorption; Antibodies; Antibodies, Neoplasm; Anticoagulants; Antithrombin III; Avidin; beta-Thromboglobulin; Biocompatible Materials; Biotin; Blood Cell Count; Bradykinin; Chromatography, Affinity; Citrates; Complement C3a; Complement C5a; Hemolysis; Hemoperfusion; Heparin; Humans; Ligands; Pancreatic Elastase; Peptide Hydrolases; Pressure; Radioimmunotherapy; Sepharose; Thrombosis | 2000 |
[Use of avidin for speedy clearance of biotinylated immunoglobulins from the blood flow].
Topics: Animals; Antibodies, Monoclonal; Avidin; Biotin; Dogs; Humans; Immunoglobulin G; Iodine Radioisotopes; Ligands; Male; Rats; Rats, Inbred Strains; Thrombosis | 1990 |